New guidelines update ART choices, endorse long-acting injectables, refine infant feeding advice, and prioritise shorter TB ...
The World Health Organization (WHO) has released updated recommendations on HIV clinical management providing new and revised guidance on antiretroviral therapy, management of vertical ...
Opinion: "While the obstacles we face may be significant, Lenacapavir represents a monumental breakthrough in the fight ...
Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game ...
WPEC CBS 12 on MSN
Florida's revised HIV treatment eligibility raises questions from Democratic lawmakers
Florida's recent decision to narrow eligibility for the Ryan White AIDS Drug Assistance Program (ADAP) is expected to limit ...
Although adolescents and young adults comprise only one quarter of the sexually active population in the United States, approximately half of new sexually transmitted infections (STIs) are diagnosed ...
Lenacapavir (LEN) is an antiviral medication used to treat and prevent HIV/AIDS and was first approved for individuals with ...
Thousands in Florida who rely on the AIDS Drug Assistance Program will see their coverage cut or their medication changed, ...
The fight to end HIV in our lifetimes just received a game-changing innovation. In June, the FDA approved Yeztugo (lenacapavir), a groundbreaking HIV prevention treatment that requires just two ...
PROVIDENCE – Infectious disease doctors and public health advocates are raising concerns as Harvard Pilgrim, a health insurance provider, plans to phase out coverage of several HIV treatments next ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results